Sutimlimab |
| Catalog No.GC66348 |
Sutimlimab, un inhibidor del subcomponente (C1s) del componente 1 de la proteÍna del complemento de primera clase, se puede utilizar para la investigaciÓn de la enfermedad de las aglutininas frÍas. C1s es una serina proteasa que escinde C4 y C2 para formar la convertasa C3.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2049079-64-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Sutimlimab, a first-in-class complement protein component 1, s subcomponent (C1s) inhibitor, can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *